- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04152772
Effect of tDCS Timing on Safety Memory in PTSD
The primary purpose of this study is to investigate the effects of tDCS timing on safety memory in PTSD. A total of 90 participants will be randomized equally across one of three groups:
- One group receiving active stimulation during extinction and sham during consolidation
- One group receiving sham stimulation during extinction and active during consolidation
- One group receiving sham stimulation both during extinction and consolidation
This study will also include an online sub-study focused on contextual processing along the PTSD spectrum. A maximum of 500 participants will be recruited using an online, panel-based platform.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a three-arm study composed of four to five visits over an approximate period of three weeks. Ninety participants will be exposed to a fear conditioning, extinction and recall paradigm at three separate study visits; one of these study visits will include active or sham transcranial direct current stimulation (tDCS) for a period of 15-20 minutes. Additional study procedures will include a screening period and two optional MRI scans, one done on study day 2 and one done on study day 5.
SUB-STUDY: The objective of this sub-study is to test performance differences between configural and elemental contextual processing in individuals across the PTSD spectrum using an online, panel-based platform. Following a within-subjects study design, up to 500 adult participants, 18-89 years, will be asked to complete experimental tasks that assess configural and elemental contextual learning and memory. They will also provide demographic information and complete questionnaires.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mascha van 't Wout-Frank, PhD
- Phone Number: 401-680-4199
- Email: mascha_vant_wout@brown.edu
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02906
- Butler Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Primary diagnosis of PTSD, assessed by the Structured Clinical Interview of DSM-5 (SCID);
- aged 18-70;
- ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent;
- Stable psychiatric medication use or treatment for at least 6 weeks.
Exclusion Criteria:
- Lifetime history of psychotic or bipolar disorder;
- Current moderate or severe substance use disorder; if mild, not under the influence at time of study participation;
- Acute suicidal or homicidal ideation as detected on screening instruments or in the investigator team's opinion, is likely to attempt suicide within 6 months;
- current (or past) significant neurological disorder, injury, or other intracranial pathology including severe traumatic brain injury or lifetime history of a) seizure disorder b) primary or secondary CNS tumors c) stroke or d) cerebral aneurysm;
- lifetime history of moderate or, current unstable medical conditions;
- Any problems that would interfere with study participation, including MRI- or tDCS-related contraindications (e.g., implanted metallic devices/substances, metallic tattoos, pregnancy, claustrophobia, holes in the skull, skin abnormalities under stimulation sites), or indication of colorblindness, or presence of any other condition or circumstance that, in the opinion of the investigator team, has the potential to prevent study completion and/or inability to schedule visit days within the allotted time, and/or to have a confounding effect on outcome assessments.
SUB-STUDY Inclusion criteria: aged 18+
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Active during extinction learning / Sham during consolidation
Active tDCS stimulation will be applied during the extinction learning phase.
Sham tDCS stimulation will be applied during the consolidation phase.
|
Active tDCS will consist of 15 minutes of 2 mA intensity once, either applied during or after extinction learning.
|
Active Comparator: Sham during extinction learning / Active during consolidation
Sham tDCS stimulation will be applied during the extinction learning phase.
Active tDCS stimulation will be applied during the consolidation phase
|
Active tDCS will consist of 15 minutes of 2 mA intensity once, either applied during or after extinction learning.
|
Sham Comparator: Sham during extinction learning / Sham during consolidation
Sham tDCS stimulation will be applied during both the extinction learning phase and the consolidation phase.
|
Active tDCS will consist of 15 minutes of 2 mA intensity once, either applied during or after extinction learning.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychophysiological reactivity
Time Frame: During fear conditioning (day 3), fear extinction (day 4) and fear extinction recall (day 5) of study protocol.
|
Change in fear response as indicated by skin conductance response
|
During fear conditioning (day 3), fear extinction (day 4) and fear extinction recall (day 5) of study protocol.
|
SUB-STUDY: accuracy in contextual processing
Time Frame: All sub-study experimental procedures will occur online and in one 'visit' and take approximately 60-90 minutes to complete.
|
Assessed by experimental tasks that assess configural and elemental contextual learning and memory.
|
All sub-study experimental procedures will occur online and in one 'visit' and take approximately 60-90 minutes to complete.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neural activity
Time Frame: MRI scans will collected on day 2 of study protocol.
|
Neural activity will be measured via MRI scans.
|
MRI scans will collected on day 2 of study protocol.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mascha van 't Wout-Frank, PhD, Brown University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1346426-5
- P20GM130452 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on transcranial direct current stimulation
-
Federal University of ParaíbaCompleted
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
University of Campinas, BrazilUnknownEpilepsy IntractableBrazil
-
Dina Hatem ElhammadyUnknown
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
University of Texas Rio Grande ValleyRecruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Federal University of ParaíbaUnknown
-
University of CalgaryAlberta Health servicesRecruitingCervicogenic HeadacheCanada
-
Universidade Federal do Rio Grande do NorteNot yet recruitingLow Back Pain | Transcranial Direct Current Stimulation
-
Nanyang Technological UniversityActive, not recruiting